Prostate Stimulation for Sexual Dysfunction
Launched by STANFORD UNIVERSITY · Jul 18, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help men who are experiencing sexual dysfunction, which can include problems like erectile dysfunction, delayed ejaculation, or not being able to reach orgasm. The study will use a special device that stimulates the prostate, with the hope of improving these symptoms. The trial is currently looking for male participants aged 18 and older who are dealing with sexual dysfunction. However, men who have had their prostate removed or those who cannot use the device for any reason will not be eligible to join.
If you decide to participate, you will be part of a study that aims to explore how this prostate stimulation might improve your sexual health. It's important to know that your involvement will help researchers understand more about this treatment option for men facing these challenges. If you meet the criteria and are interested, this could be a valuable opportunity to potentially improve your sexual wellness.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males \>18 years of age suffering from sexual dysfunction
- Exclusion Criteria:
- • Individuals who have had a prostatectomy - removal of prostate
- • Inability to operate the device for any reason
- • Females
- • Males \<18 years of age
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Michael Eisenberg, M.D.
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials